在持续使用抗血栓性药物治疗延迟多斑管术后出血的过程中,冷管多斑管术的安全性:试点研究
Junnosuke Hayasaka1, Satoshi Yamashita1, Akira Matsui1
1Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.
Digestive diseases (Basel, Switzerland)
|May 26, 2023
概括
对于持续接受抗血栓治疗的患者来说,冷陷多角切除术是安全的. 这种内镜手术没有显示出延迟出血风险的增加,这表明它可以安全地进行.
科学领域:
- 胃肠病学 胃肠病学
- 内镜手术 进行内镜手术
- 心脏病学 心脏病学
背景情况:
- 冷陷多角切除术 (CSP) 是一种内镜技术,具有较低的延迟出血率.
- 持续抗血栓治疗期间CSP的安全性尚不清楚.
- 这项研究调查了在接受CSP而接受抗血栓治疗的患者中延迟多角切除术后出血的风险.
研究的目的:
- 确定在继续抗血栓治疗的患者中进行冷陷多角切除术的安全性.
- 为了比较继续治疗的患者和停止抗血栓治疗的患者之间的延迟多片切除术后出血率.
主要方法:
- 2015年1月至2021年12月期间接受CSP的患者的回顾性队列研究.
- 根据使用抗血栓药物的情况,患者被分为继续和停药组.
- 倾向性得分匹配用于控制混变量,然后比较延迟出血率.
主要成果:
- 在匹配之前,延迟出血发生在继续组的1.5%和戒断组的0.3% (p=0.23).
- 在倾向性得分匹配后,继续组的0.9%经历了延迟出血,而戒断组的这一比例为0%.
- 两组之间没有观察到延迟多斑切除术后出血率的统计学上显著差异.
结论:
- 在持续接受抗血栓治疗的患者中,可以安全地进行冷陷多角切除术.
- 持续的抗血栓治疗不会显著增加冷陷多角切除术后延迟出血的风险.
- 这些发现支持在需要抗血栓剂的患者中继续使用CSP.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
571
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
571
Anticoagulant Drugs: Low-Molecular-Weight Heparins
775
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
775
Venous Thrombosis III: Interprofessional Care
12
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
12
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Epistaxis
212
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
212
Cardiac Catheterization IV: Nursing Management
80
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
80


